WeVote
Log In

Bill

Bill

SB 2651

$ALS FOUNDATION

104th Regular Session Introduced by Mary Edly-Allen and 3 co-sponsors

Illinois SB 2651 would establish state funding for ALS research, treatment, and patient services to address the progressive neurodegenerative disease.

Added as Co-Sponsor Sen. Graciela Guzmán
0
WeVote Research Nonpartisan
Bill Summary · SB 2651

Legislative bill overview

SB 2651 establishes a dedicated funding mechanism or appropriation for ALS (amyotrophic lateral sclerosis) research, treatment, or patient support services in Illinois. The bill was introduced by three state senators and has progressed through initial legislative readings as of late June 2025.

Why is this important

ALS is a progressive neurodegenerative disease with no cure and significant mortality rates, creating substantial healthcare and financial burdens for patients and families. State-level funding can support research acceleration, clinical trial access, and patient assistance programs that may not be adequately covered by federal resources or private funding alone.

Potential points of contention

  • Budget prioritization: Legislators may debate whether dedicated state funding for a specific disease is the best use of limited healthcare budgets compared to general disease research or other health priorities
  • Funding mechanism unclear: Without seeing the bill text, it's unknown whether this creates new appropriations, redirects existing funds, or establishes a tax/fee mechanism, which affects broader fiscal concerns
  • Scope limitations: Questions may arise about whether the funding targets only research, patient services, or both, and whether it serves all Illinoisans or specific populations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.